Literature DB >> 18083942

Evolution, aging, and osteoporosis.

Stephanie Tung1, Jameel Iqbal.   

Abstract

Aging is a process whereby organisms lose to the capacity to effectively handle life's stresses. Associated with aging are pathophysiological processes, such as decreases in bone mass, which in the extreme form lead to significant morbidity. Evolutionary theory suggests that these pathophysiological processes are permitted to occur because an organism need only preserve its body against stress only for the amount of time needed for effective reproduction. In this review, an understanding of osteoporosis and bone loss is discussed within the context of aging theory. Specific topics covered include: (1) bone loss as an antagonistically pleiotropic physiological process, (2) age-associated stress accumulation and its negative impact on bone turnover, and (3) the mechanisms whereby gonadal failure, increases in inflammatory cytokines, and cellular bone marrow changes lead to bone loss. This review concludes by examining purported hypotheses in the context of Werner's syndrome, a disease characterized by premature aging. We suggest that future osteoporosis therapy will likely focus on prevention of aging in general as a means to prevent the development of osteoporosis.

Entities:  

Mesh:

Year:  2007        PMID: 18083942     DOI: 10.1196/annals.1402.080

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

1.  Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies.

Authors:  Lili Ma; Ling Oei; Lindi Jiang; Karol Estrada; Huiyong Chen; Zhen Wang; Qiang Yu; Maria Carola Zillikens; Xin Gao; Fernando Rivadeneira
Journal:  Eur J Epidemiol       Date:  2012-03-27       Impact factor: 8.082

Review 2.  Function of matrix IGF-1 in coupling bone resorption and formation.

Authors:  Janet L Crane; Xu Cao
Journal:  J Mol Med (Berl)       Date:  2013-09-26       Impact factor: 4.599

3.  Ebselen Is a Potential Anti-Osteoporosis Agent by Suppressing Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Osteoclast Differentiation In vitro and Lipopolysaccharide-Induced Inflammatory Bone Destruction In vivo.

Authors:  Jong Min Baek; Ju-Young Kim; Kwon-Ha Yoon; Jaemin Oh; Myeung Su Lee
Journal:  Int J Biol Sci       Date:  2016-02-18       Impact factor: 6.580

4.  Dynamic Spatiotemporal Expression Pattern of the Senescence-Associated Factor p16Ink4a in Development and Aging.

Authors:  Hasan Safwan-Zaiter; Nicole Wagner; Jean-François Michiels; Kay-Dietrich Wagner
Journal:  Cells       Date:  2022-02-04       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.